中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Synthesis and acetylcholinesterase inhibitory activity of huperzine A-E2020 combined compound

文献类型:期刊论文

作者Zeng, FX; Jiang, HL; Zhai, YF; Zhang, HY; Chen, KX; Ji, RY
刊名BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
出版日期1999-12-06
卷号9期号:23页码:3279-3284
ISSN号0960-894X
DOI10.1016/S0960-894X(99)00597-1
文献子类Article
英文摘要The synthesis of huperzine-E2020 combined compound (3) has been accomplished and the activities of 3 and the intermediates 12 and 13 to inhibit the activity of acetylcholinesterase have been measured. Conformation analyses and molecular docking studies of E2020 and the eight isomers of 12 were carried out. The results indicated that binding energies of all isomers of 12 with AChE was much lowe; than E2020 except for isomer RRZ, which might be the reason that the activity of 12 was lower than that of E2020. Interaction pattern of RRZ in AChE was also studied. Both binding energy and interaction pattern shows that the biological activity of RRZ might be higher than that of E2020. (C) 1999 Elsevier Science Ltd. Ail rights reserved.
WOS研究方向Pharmacology & Pharmacy ; Chemistry
语种英语
WOS记录号WOS:000084153400005
出版者PERGAMON-ELSEVIER SCIENCE LTD
源URL[http://119.78.100.183/handle/2S10ELR8/274669]  
专题中国科学院上海药物研究所
通讯作者Zeng, FX
作者单位Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China
推荐引用方式
GB/T 7714
Zeng, FX,Jiang, HL,Zhai, YF,et al. Synthesis and acetylcholinesterase inhibitory activity of huperzine A-E2020 combined compound[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,1999,9(23):3279-3284.
APA Zeng, FX,Jiang, HL,Zhai, YF,Zhang, HY,Chen, KX,&Ji, RY.(1999).Synthesis and acetylcholinesterase inhibitory activity of huperzine A-E2020 combined compound.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,9(23),3279-3284.
MLA Zeng, FX,et al."Synthesis and acetylcholinesterase inhibitory activity of huperzine A-E2020 combined compound".BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 9.23(1999):3279-3284.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。